Related references
Note: Only part of the references are listed.KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update Foreword
Michael V. Rocco et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Lipid-Lowering Therapy in Persons With Chronic Kidney Disease A Systematic Review and Meta-analysis
Ashish Upadhyay et al.
ANNALS OF INTERNAL MEDICINE (2012)
Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease A Systematic Review and Meta-analysis
Suetonia C. Palmer et al.
ANNALS OF INTERNAL MEDICINE (2012)
Reduction in atherosclerotic events: a retrospective study in an outpatient cardiology practice
Anthony D. Mercando et al.
ARCHIVES OF MEDICAL SCIENCE (2012)
Lipid-lowering therapies and achievement of LDL-cholesterol targets
Manfredi Rizzo et al.
ARCHIVES OF MEDICAL SCIENCE (2012)
Clinical assessment and management of dyslipidemia in patients with chronic kidney disease
Kosaku Nitta
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Effect of statins on chronic inflammation and nutrition status in renal dialysis patients: A systematic review and meta-analysis
Jin Deng et al.
NEPHROLOGY (2012)
Lipids, blood pressure, kidney - what was new in 2011?
Marcin Barylski et al.
ARCHIVES OF MEDICAL SCIENCE (2011)
IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease risk factors by multifactorial interVEntion. The IMPERATIVE renal analysis
Vasilios G. Athyros et al.
ARCHIVES OF MEDICAL SCIENCE (2011)
Statin use is associated with lower inflammation and erythropoietin responsiveness index in hemodialysis patients
Mehmet Koc et al.
HEMODIALYSIS INTERNATIONAL (2011)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
Statins in patients with chronic kidney disease: why, who and when?
Anna Gluba et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Nephroprotective and clinical potential of statins in dialyzed patients
Jacek Rysz et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Bengt C. Fellstroem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The calcium acetate renagel evaluation-2 (CARE-2) study
Wajeh Qunibi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Atherogenesis in renal patients: A model of vascular disease?
Georgios Efstratiadis et al.
CURRENT VASCULAR PHARMACOLOGY (2008)
Effects of lipid-lowering therapy with rosuvastatin on atherosclerotic burden in patients with chronic kidney disease
Yukako Sawara et al.
INTERNAL MEDICINE (2008)
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease
James Shepherd et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease
Prabath W. B. Nanayakkara et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
A Randomized trial of the effect of statin and fibrate therapy on arterial function in CKD
Gursharan Dogra et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study
K. Yamagata et al.
KIDNEY INTERNATIONAL (2007)
Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease
Marian Goicoechea et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients
V Panichi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease
T Nakamura et al.
AMERICAN JOURNAL OF NEPHROLOGY (2006)
Safety and efficacy of atorvastatin in patients with severe renal dysfunction
B Holmberg et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2005)
Effect of Rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease
A Verma et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Effects of fluvastatin treatment on lipid profile, C-reactive protein trend, and renal function in dyslipidemic patients with chronic renal failure
L Di Lullo et al.
ADVANCES IN THERAPY (2005)
Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition beyond low-density lipoprotein cholesterol
JK Liao
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
C Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis
KA Dornbrook-Lavender et al.
PHARMACOTHERAPY (2005)
Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the atherosclerosis risk in communities study
P Muntner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on renal function
M Epstein et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Effect of pravastatin on cardiovascular events in people with chronic kidney disease
M Tonelli et al.
CIRCULATION (2004)
The effect of long-term aggressive lipid lowering on ischemic and atherosclerotic burden in patients with chronic kidney disease
R Fathi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease
S Bianchi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus
A Ichihara et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients
JW Chang et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Safety and efficacy of simastatin in hypercholesterolemic patients undergoing chronic renal dialysis
D Saltissi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients
F Mallamaci et al.
KIDNEY INTERNATIONAL (2002)
Cardiovascular disease in end-stage renal disease patients
AJ Collins et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Share Paper
